@jhpsychedelics
The Center for Psychedelic and Consciousness Research studies how psychedelics affect behavior, mood, cognition, brain function, & biological markers of health. hopkinspsychedelic.org
Thrilled to announce our new CME course on psychedelic medicine, taught by CPCR faculty!
Designed for physicians, advanced practice providers, mental health clinicians, & anyone interested in psychedelic medicine.
✔ Up to 6.5 CME/CE credits
📅 March 27, 2026 | Live Online
🔗 tinyurl.com/hopkinscme
Ready for a weekend of science at the International Society for Research on Psychedelics (ISRP)
New pilot study from Johns Hopkins finds psilocybin-assisted treatment was associated with significant and sustained benefits in post-treatment Lyme disease, including improved mood, fatigue, sleep, pain, and quality of life for up to 6 months. More research is needed to confirm. Read more below 👇
Huge congratulations to Dr. Albert Garica-Romeu who was recently named a Frontiers of Science Fellow by the National Academy of Sciences! tinyurl.com/2cbkt93c
A new review in Psychiatric Times examines adverse event data for psilocybin, MDMA, ketamine, and ibogaine, finding meaningful differences in risk and inconsistent reporting. Clear compound-level distinctions are crucial as access expands.
www.psychiatrictimes.com/view/adverse...
Dr. Fred Barrett co-authored a new paper on the challenges of running rigorous psychedelic clinical trials — from expectancy effects to blinding. As therapies near FDA approval, strong science is essential.
Read more: journals.sagepub.com/doi/10.1177/...
🔬 We are hiring a Research Data Analyst. Learn more and apply: hiring.jhu.edu/careers?quer...
Dr. Brandon Weiss explores how MDMA and psilocybin may help rewire fear patterns in PTSD, including a new PAMVET trial on combining the two. Learn more below.https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how
CPCR Medical Director Dr. Sandeep Nayak weighs in on where psilocybin therapy for PTSD is headed – from policy shifts to clinical progress and what it means for the future of care www.lucid.news/legislation-...
We're excited to unveil our redesigned CPCR website! Whether you're interested in participating in cutting-edge clinical trials, exploring our research publications, or accessing information about our integration clinic and online courses. Check it out!
hopkinspsychedelic.org
Can psilocybin assisted therapy reduce opioid use and improve quality of life? We are seeking people near Baltimore, Maryland with Opioid Use Disorder to participate in a trial to see if psilocybin can reduce opioid use and improve quality of life. jhmi.co1.qualtrics.com/jfe/form/SV_...
The Psychedelic Archives Project Guest Speaker Series continues this Wednesday with Dr. Nicolas Langlitz.
🗓 February 11th, 2026 | ⏰ 4:30 PM EST
🎟 Attendance is free — registration link below 👇
jhubluejays.zoom.us/j/92622903856
Ongoing debate about psychological support versus psychotherapy in psychedelic trials often stems from vague definitions. Clarifying these constructs is essential for rigorous study of safety and efficacy.
Join us Wednesday for the Psychedelic Archives Project Guest Speaker Series!
🎤 Dr. Larissa Carneiro
🗓 January 28, 2026 | ⏰ 4:30 PM EST
🎟 Free to attend — sign up at the link below! 👇
jhubluejays.zoom.us/j/92622903856
Have you had separate experiences with psychedelics and cannabis? Take our short survey to help expand research on their effects:
tinyurl.com/psyches-cann...
Enroll in Psychedelics and Medicine on Coursera: www.coursera.org/learn/psyche...
Learn more about our course here: www.hopkinsmedicine.org/news/article...
Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based insight into how they work and who may benefit. Ideal for clinicians, students, researchers, and curious learners. Enroll below 👇
SEEKING HEALTHY VOLUNTEERS FOR A PSYCHEDELIC STUDY
🔗 tinyurl.com/34jnz3d5
📞 410-550-2253
✉️ psilocybinbrainstudy@jhmi.edu
Dr. Brandon Weiss spoke on psychedelic therapy at the AcademyHealth conference for VA clinicians. Thanks to Dr. Matthew Boehm and fellow panelists. CPCR is focused on implementing these therapies in healthcare.
Join us- the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on today Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇
jhubluejays.zoom.us/j/92622903856
Want to help researchers better understand how psychedelic experiences impact mood and cognitive functioning? Please take part in our anonymous survey! jhmi.co1.qualtrics.com/jfe/form/SV_...
Next up in the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇
jhubluejays.zoom.us/j/92622903856
On Thursday December 11, it was Dr. Brandon Weiss', Dr. Fred Barrett's, and Dr. Bit Yaden's honor to host Bradley Plunkett, Mikayla Harris, and Katie Johnston, professional staff members of Senator Jerry Moran, Chairman of the Senate Committee of Veteran Affairs
More details: x.com/JHPsychedeli...
On Tuesday December 9, CPCR Director Dr. Fred Barrett and Assistant Professor Dr. Brandon Weiss took part in a roundtable exchange among VA representatives, researchers, and veteran groups organized by the Senate Committee on Veteran Affairs.
For more details:
x.com/JHPsychedeli...
Dr. David Yaden was interviewed by The Harvard Gazette on the need for large, rigorous NIH-funded psychedelic research.
This idea needs to be tested, and we hope our review helps shape that work.
We are eager to see new studies examine these distinct cognitive processes with more precision. A particularly intriguing possibility is that increases in flexible thinking after psychedelic sessions may create a window for meaningful psychological change.
